COVID-19 Multiplex RT-qPCR Test

Detection of SARS-CoV-2 RNA from individuals suspected of COVID-19

COVID-19 Multiplex RT-qPCR Test is a in vitro diagnostic test intended for the qualitative detection of nucleic acids from SARS-CoV-2. It allows an increase of the test capacity, as one patient sample is analyzed in a single PCR tube instead of three tubes. The test analyzes two SARS-CoV-2 sequences as well as human RNase is designed for use on standard real-time PCR platforms with FAM,
HEX/VIC and Cy5 channels.

The tests are available either as Dispense Ready or Ready-To-Use  versions.

The Dispense Ready version includes Primer-Probe Mix and Master Mix in separate tubes for dispensing in own plastic products before adding RNA. The Ready-To-Use version is pre-dispensed into 8-tube PCR strips, and only RNA must be added before RT-qPCR analysis.

  • Multiplex RT qPCRTest assay for increased testing capacity
  • Designed to be used on standard laboratory equipment
  • Based on WHO guidelines (N1, N2 and RNAse P)
  • Includes SARS-CoV-2 RNA positive control panels
  • Produced in Europe
  • High Sensivity (LOD<5 copies per analysis)
  • CE IVD certified